Why? Guess I asked twice about the diabetes bus
Post# of 11802
Guess I asked twice about the diabetes business and never got a response. So the response was surprising.
FDA/SEC?
I think Berman’s Covid Kits are all but FDA approved. Maybe some tweaks, but the US and world need a rapid-swift-reliable-inexpensive kit solution. Think it happens sooner vs later.
Don’t know, but I still have no idea what the SEC issues are. Insider trading? False statements? Don’t really know, frankly don’t care. Think it’s BS and ultimately a non-issue.
So in my feeble mind, it’s EUA and go to market. And I expect lots of US reinforcement help to increase production.
So, when all is said and done it leaves the diabetic portfolio as another opportunity for the company. And my question was, does the Covid-19 kit hypothetical approval kick open the door for the diabetic profile?